Cargando…
Clinical implications of mutational analysis in gastrointestinal stromal tumours
The management of localised and advanced gastrointestinal stromal tumours (GISTs) in terms of histological diagnosis, surgery, imaging, medical treatment and molecular biology has rapidly changed since introduction of imatinib mesylate for molecularly targeted therapy in 2000. In this minireview, we...
Autores principales: | Hoeben, A, Schöffski, P, Debiec-Rychter, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259190/ https://www.ncbi.nlm.nih.gov/pubmed/18253129 http://dx.doi.org/10.1038/sj.bjc.6604217 |
Ejemplares similares
-
Impact of tumour rupture risk on the oncological rationale for the surgical treatment choice of gastrointestinal stromal tumours
por: Peparini, Nadia
Publicado: (2023) -
Ghrelin and gastrointestinal stromal tumors
por: Zhu, Chang-Zhen, et al.
Publicado: (2017) -
Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors
por: Van Looy, Thomas, et al.
Publicado: (2014) -
Angiogenesis in gastrointestinal stromal tumors: From bench to bedside
por: Papadakos, Stavros P, et al.
Publicado: (2022) -
How best to manage gastrointestinal stromal tumor
por: Lanke, Gandhi, et al.
Publicado: (2017)